Coherus Oncology, Inc. (NASDAQ:CHRS) Q1 2026 Earnings Call Transcript
Coherus Oncology, Inc. (NASDAQ:CHRS) Q1 2026 Earnings Call Transcript May 11, 2026Coherus Oncology, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.26333.




